31
Modifiable risk factors for AMD
59. Kamburoglu G, Gumus K, Kadayifcilar S, Eldem B. Plasma ho-
mocysteine, vitamin B12 and folate levels in age-related macular
degeneration. Graefes Arch Clin Exp Ophthalmol 2006; 244 (5):
565-569.
60. Nowak M, Swietochowska E, Wielkoszynski T, Marek B, Kos-
Kudla B, Szapska B, Kajdaniuk D, Glogowska-Szelag J, Sieminska
L, Ostrowska Z, Koziol H, Klimek J. Homocysteine, vitamin B12,
and folic acid in age-related macular degeneration. Eur J Ophthal-
mol 2005; 15 (6): 764-767.
61. Axer-Siegel R, Bourla D, Ehrlich R, Dotan G, Benjamini Y, Gav-
endo S, Weinberger D, Sela BA. Association of neovascular age-
related macular degeneration and hyperhomocysteinemia. Am J
Ophthalmol 2004; 137 (1): 84-89.
62. Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomark-
ers of cardiovascular disease as risk factors for age-related macular
degeneration. Ophthalmology 2005; 112 (12): 2076-2080.
63. Seddon JM, Gensler G, Klein ML, Milton RC. Evaluation of plas-
ma homocysteine and risk of age-related macular degeneration.
Am J Ophthalmol 2006; 141 (1): 201-203.
64. Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic
acid, pyridoxine, and cyanocobalamin combination treatment and
age-related macular degeneration in women: the Women’s Anti-
oxidant and Folic Acid Cardiovascular Study. Arch Intern Med
2009; 169 (4): 335-341.
65. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Asso-
ciation between vitamin D and age-related macular degeneration
in the Third National Health and Nutrition Examination Survey,
1988 through 1994. Arch Ophthalmol 2007; 125 (5): 661-669.
66. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and
the impact of blue light hazard. Acta Ophthalmol Scand 2006;
84 (1): 4-15.
67. Taylor HR, West S, Muñoz B, Rosenthal FS, Bressler SB, Bressler
NM. The long-term effects of visible light on the eye. Arch Oph-
thalmol 1992; 110 (1): 99-104.
68. Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related
macular degeneration. The Beaver Dam Eye Study. Arch Ophthal-
mol 1993; 111 (4): 514-518.
69. Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD.
Sunlight and the 10-year incidence of age-related maculopathy:
the Beaver Dam Eye Study. Arch Ophthalmol 2004; 122 (5): 750-
757.
70. [No authors listed]. Risk factors for neovascular age-related macu-
lar degeneration. The Eye Disease Case-Control Study Group.
Arch Ophthalmol 1992; 110 (12): 1701-1708.
71. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor
HR72. Risk factors for age-related maculopathy: the Visual Im-
pairment Project. Arch Ophthalmol 2001; 119 (10): 1455-1462.
72. Delcourt C, Carriere I, Ponton-Sanchez A, Fourrey S, Lacroux A,
Papoz L. Light exposure and the risk of age-related macular de-
generation: the Pathologies Oculaires Liées a l’Age (POLA) study.
Arch Ophthalmol 2001; 119 (10): 1463-1468.
73. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related
macular degeneration. An Australian case-control study. Ophthal-
mology 1997; 104 (5): 770-776.
74. Pham TQ, Rochtchina E, Mitchell P, Smith W, Wang JJ. Sunlight-
related factors and the 10-year incidence of age-related maculopa-
thy. Ophthalmic Epidemiol 2009; 16 (2): 136-141.
75. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related
macular degeneration after extracapsular cataract extraction with
intraocular lens implantation. Ophthalmology 1996; 103 (10):
1546-1554.
76. Ho L, Boekhoorn SS, Liana, van Duijn CM, Uitterlinden AG,
Hofman A, de Jong PT, Stijnen T, Vingerling JR. Cataract surgery
and the risk of aging macula disorder: the rotterdam study. Invest
Ophthalmol Vis Sci 2008; 49 (11): 4795-800.
77. Kaiserman I, Kaiserman N, Elhayany A, Vinker S. Cataract sur-
gery is associated with a higher rate of photodynamic therapy for
age-related macular degeneration. Ophthalmology. 2007; 114 (2):
278-282.
78. Cugati S, Mitchell P, Rochtchina E, Tan AG, Smith W, Wang JJ.
Cataract surgery and the 10-year incidence of age-related macu-
lopathy: the Blue Mountains Eye Study. Ophthalmology 2006;
113 (11): 2020-2025.
79. Wang JJ, Klein R, Smith W, Klein BE, Tomany S, Mitchell P. Cata-
ract surgery and the 5-year incidence of late-stage age-related macu-
lopathy: pooled findings from the Beaver Dam and Blue Moun-
tains eye studies. Ophthalmology 2003; 110 (10): 1960-1967.
80. Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ. The
association of cataract and cataract surgery with the long-term inci-
dence of age-related maculopathy: the Beaver Dam eye study. Arch
Ophthalmol 2002; 120 (11): 1551-1558.
81. Pham TQ, Cugati S, Rochtchina E, Mitchell P, Maloof A, Wang
JJ. Early age-related maculopathy in eyes after cataract surgery. Eye
2007; 21 (4): 512-517.
82. Sutter FK, Menghini M, Barthelmes D, Fleischhauer JC, Kurz-
Levin MM, Bosch MM, Helbig H. Is pseudophakia a risk factor for
neovascular age-related macular degeneration? Invest Ophthalmol
Vis Sci 2007; 48 (4): 1472-1475.
83. Chew EY, Sperduto RD, Milton RC, Clemons TE, Gensler GR,
Bressler SB, Klein R, Klein BE, Ferris FL, III. Risk of advanced
age-related macular degeneration after cataract surgery in the Age-
Related Eye Disease Study: AREDS report 25. Ophthalmology
2009; 116 (2): 297-303.
84. Braunstein RE, Sparrow JR. A blue-blocking intraocular lens
should be used in cataract surgery. Arch Ophthalmol 2005; 123(4):
547-549.
85. Delcourt C, Korobelnik JF, Barberger Gateau P, et al. Nutrition
and age-related eye diseases : the ALIENOR (Antioxydants, Lipi-
des Essentiels, Nutrition et maladies Oculaires) Study. Journal Nutr
Health Aging. 2010; (in press).
